MPs hear Richards review skirted major top-up areas

The government’s decision to allow co-payments for private treatments assumed it is best to make expensive drugs ‘as freely available as possible’, MPs have been told.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here